A Randomized Prospective Double-Blind Comparison Trial of Clomiphene Citrate and Anastrozole in Raising Testosterone in Hypogonadal Infertile Men

Journal of Sexual Medicine

Volumn 12, Issue 8, 2015, Pages 1761-1769

  Helo, Sevann ^a   Ellen, Joseph ^a   Mechlin, Clay ^b   Feustel, Paul ^c   Grossman, Michael ^d   Ditkoff, Edward ^d   Mccullough, Andrew ^a  

^a ALBANY MEDICAL CENTER   (United States)

^b Urology Associates of Central Missouri   (United States)

^c ALBANY MEDICAL COLLEGE   (United States)

^d CNY Fertility Center   (United States)

Author keywords

Anastozole; Clomiphene Citrate; Hypogonadism; Infertility; Testosterone

Indexed keywords

ANASTROZOLE; CLOMIFENE CITRATE; ESTRADIOL; FOLLITROPIN; LUTEINIZING HORMONE; SEX HORMONE BINDING GLOBULIN; TESTOSTERONE; CLOMIFENE; FERTILITY PROMOTING AGENT; HORMONE; NITRILE; TRIAZOLE DERIVATIVE;

ARTICLE; BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG RESPONSE; DRUG SAFETY; HORMONE DETERMINATION; HUMAN; HYPOGONADISM; MALE; MALE INFERTILITY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUANTITATIVE ANALYSIS; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; SEMEN ANALYSIS; BLOOD; COMPARATIVE STUDY; DEFICIENCY; INFERTILITY, MALE; TREATMENT OUTCOME;

CLOMIPHENE; DOUBLE-BLIND METHOD; FERTILITY AGENTS, MALE; FOLLICLE STIMULATING HORMONE; HORMONES; HUMANS; HYPOGONADISM; INFERTILITY, MALE; LUTEINIZING HORMONE; MALE; NITRILES; PROSPECTIVE STUDIES; TESTOSTERONE; TREATMENT OUTCOME; TRIAZOLES;

EID: 84939549782     PISSN: 17436095     EISSN: 17436109     Source Type: Journal    
DOI: 10.1111/jsm.12944     Document Type: Article

References (48)

1. Araujo AB, Esche GR, Kupelian V, O'Donnell AB, Travison TG, Williams RE, Clark RV, McKinlay JB. Prevalence of symptomatic androgen deficiency in men. J Clin Endocrinol Metab 2007;92:4241-4247.
2. Sigman M, Jarow JP. Endocrine evaluation of infertile men. Urology 1997;50:659-664.
3. Patel DP, Brant WO, Myers JB, Zhang C, Presson AP, Johnstone EB, Dorais JA, Aston KI, Carrell DT, Hotaling JM. Sperm concentration is poorly associated with hypoandrogenism in infertile men. Urology 2015;85:1-5.
4. McLachlan RI. The endocrine control of spermatogenesis. Baillieres Best Pract Res Clin Endocrinol Metab 2000;14:345-362.
5. Wang C, Nieschlag E, Swerdloff R, Behre H, Hellstrom W, Gooren L, Kaufman J, Legros J-J, Lunenfeld B, Morales A, Morley J, Achulman C, Thompson I, Weidner W, Wu F. Investigation, treatment and monitoring of late-onset hypogonadism in males: ISA, ISSAM, EAU, EAA and ASA recommendations. Eur J Endocrinol 2008;159:507-514.
6. Corona G, Rastrelli G, Monami M, Guay A, Buvat J, Sforza A, Forti G, Mannucci E, Maggi M. Hypogonadism as a risk factor for cardiovascular mortality in men: A meta-analytic study. Eur J Endocrinol 2011;165:687-701.
7. Jarow JP, Chen H, Rosner TW, Trentacoste S, Zirkin BR. Assessment of the androgen environment within the human testis: Minimally invasive method to obtain intratesticular fluid. J Androl 2001;22:640-645.
8. Jarow JP, Zirkin BR. The androgen microenvironment of the human testis and hormonal control of spermatogenesis. Ann N Y Acad Sci 2005;1061:208-220.
9. Santen RJ. Feedback control of luteinizing hormone and follicle-stimulating hormone secretion by testosterone and estradiol in men: Physiological and clinical implications. Clin Biochem 1981;14:243-251.
10. Finkelstein JS, O'Dea LS, Whitcomb RW, Crowley WF Jr. Sex steroid control of gonadotropin secretion in the human male. II. Effects of estradiol administration in normal and gonadotropin-releasing hormone-deficient men. J Clin Endocrinol Metab 1991;73:621-628.
11. Kumar R, Gautam G, Gupta NP. Drug therapy for idiopathic male infertility: Rationale versus evidence. J Urol 2006;176(4 Pt 1):1307-1312.
12. Ghanem H, Shaeer O, El-Segini A. Combination clomiphene citrate and antioxidant therapy for idiopathic male infertility: A randomized controlled trial. Fertil Steril 2010;93:2232-2235.
13. World Health Organization. A double-blind trial of clomiphene citrate for the treatment of idiopathic male infertility. Int J Androl 1992;15:299-307.
14. Patankar SS, Kaore SB, Sawane MV, Mishra NV, Deshkar AM. Effect of clomiphene citrate on sperm density in male partners of infertile couples. Indian J Physiol Pharmacol 2007;51:195-198.
15. Matsumiya K, Kitamura M, Kishikawa H, Kondoh N, Fujiwara Y, Namiki M, Okuyama A. A prospective comparative trial of a gonadotropin-releasing hormone analogue with clomiphene citrate for the treatment of oligoasthenozoospermia. Int J Urol 1998;5:361-363.
16. Moradi M, Moradi A, Alemi M, Ahmadnia H, Abdi H, Ahmadi A, Bazargan-Hejazi S. Safety and efficacy of clomiphene citrate and L-carnitine in idiopathic male infertility: A comparative study. Urol J 2010;7:188-193.
17. Pavlovich CP, King P, Goldstein M, Schlegel PN. Evidence of a treatable endocrinopathy in infertile men. J Urol 2001;165:837-841.
18. Raman JD, Schlegel PN. Aromatase inhibitors for male infertility. J Urol 2002;167(2 Pt 1):624-629.
19. Gregoriou O, Bakas P, Grigoriadis C, Creatsa M, Hassiakos D, Creatsas G. Changes in hormonal profile and seminal parameters with use of aromatase inhibitors in management of infertile men with low testosterone to estradiol ratios. Fertil Steril 2012;98:48-51.
20. Mohamed O, Freundlich RE, Dakik HK, Grober E, Najari B, Lipshultz L, Khera M. The quantitative ADAM questionnaire: A new tool in quantifying the severity of hypogonadism. Int J Impot Res 2010;22:20-24.
21. Morley JE, Charlton E, Patrick P, Kaiser F, Cadeau P, McCready D, Perry H. Validation of a screening questionnaire for androgen deficiency in aging males. Metabolism 2000;49:1239-1242.
22. Smith LB, Walker WH. The regulation of spermatogenesis by androgens. Semin Cell Dev Biol 2014;30:2-13.
23. Harman SM, Metter EJ, Tobin JD, Pearson J, Blackman MR, Baltimore Longitudinal Study of Aging. Longitudinal effects of aging on serum total and free testosterone levels in healthy men. Baltimore Longitudinal Study of Aging. J Clin Endocrinol Metab 2001;86:724-731.
24. Mohr BA, Guay AT, O'Donnell AB, McKinlay JB. Normal, bound and nonbound testosterone levels in normally ageing men: Results from the Massachusetts Male Ageing Study. Clin Endocrinol (Oxf) 2005;62:64-73.
25. Sikaris K, McLachlan RI, Kazlauskas R, de Kretser D, Holden CA, Handelsman DJ. Reproductive hormone reference intervals for healthy fertile young men: Evaluation of automated platform assays. J Clin Endocrinol Metab 2005;90:5928-5936.
26. Bhasin S, Cunningham GR, Hayes FJ, Matsumoto A, Snyder P, Swerdloff R, Montori V. Testosterone therapy in men with androgen deficiency syndromes: An Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 2010;95:2536-2559.
27. Satkunasivam R, Ordon M, Hu B, Mullen B, Lo K, Grober E, Jarvi K. Hormone abnormalities are not related to the erectile dysfunction and decreased libido found in many men with infertility. Fertil Steril 2014;101:1594-1598.
28. Leder BZ, Rohrer JL, Rubin SD, Gallo J, Longcope C. Effects of aromatase inhibition in elderly men with low or borderline-low serum testosterone levels. J Clin Endocrinol Metab 2004;89:1174-1180.
29. de Ronde W. Therapeutic uses of aromatase inhibitors in men. Curr Opin Endocrinol Diabetes Obes 2007;14:235-240.
30. Guay AT, Bansal S, Heatley GJ. Effect of raising endogenous testosterone levels in impotent men with secondary hypogonadism: Double blind placebo-controlled trial with clomiphene citrate. J Clin Endocrinol Metab 1995;80:3546-3552.
31. Moskovic DJ, Katz DJ, Akhavan A, Park K, Mulhall JP. Clomiphene citrate is safe and effective for long-term management of hypogonadism. BJU Int 2012;110:1524-1528.
32. Kaminetsky J, Werner M, Fontenot G, Wiehle RD. Oral enclomiphene citrate stimulates the endogenous production of testosterone and sperm counts in men with low testosterone: Comparison with testosterone gel. J Sex Med 2013;10:1628-1635.
33. Shabsigh A, Kang Y, Shabsign R, Gonzalez M, Liberson G, Fisch H, Goluboff E. Clomiphene citrate effects on testosterone/estrogen ratio in male hypogonadism. J Sex Med 2005;2:716-721.
34. T'Sjoen GG, Giagulli VA, Delva H, Crabbe P, De Bacquer D, Kaufman JM. Comparative assessment in young and elderly men of the gonadotropin response to aromatase inhibition. J Clin Endocrinol Metab 2005;90:5717-5722.
35. Burnett-Bowie SA, McKay EA, Lee H, Leder BZ. Effects of aromatase inhibition on bone mineral density and bone turnover in older men with low testosterone levels. J Clin Endocrinol Metab 2009;94:4785-4792.
36. Elder K, Hawi R, Al Solaiman F. Inflammatory bowel disease-related thoracic aortic thrombosis. South Med J 2010;103:172-174.
37. Owczarek D, Cibor D, Glowacki MK, Rodacki T, Mach T. Inflammatory bowel disease: Epidemiology, pathology and risk factors for hypercoagulability. World J Gastroenterol 2014;20:53-63.
38. Grip O, Svensson PJ, Lindgren S. Inflammatory bowel disease promotes venous thrombosis earlier in life. Scand J Gastroenterol 2000;35:619-623.
39. Novacek G, Weltermann A, Sobala A, Tilg H, Petritsch W, Reinisch W, Mayer A, Haas T, Kaser A, Feichtenschlage T, Fuchssteiner H, Knoflach P, Vogelsang H, Miehsler W, Platzer R, Tillinger W, Jaritz B, Schmid A, Blaha B, Dejaco C, Eichinger S. Inflammatory bowel disease is a risk factor for recurrent venous thromboembolism. Gastroenterology 2010;139:779-787, 787 e771.
40. Zezos P, Kouklakis G, Saibil F. Inflammatory bowel disease and thromboembolism. World J Gastroenterol 2014;20:13863-13878.
41. Standridge S, de los Reyes E. Inflammatory bowel disease and cerebrovascular arterial and venous thromboembolic events in 4 pediatric patients: A case series and review of the literature. J Child Neurol 2008;23:59-66.
42. Lund Kristensen S, Ahlehoff O, Lindhardsen J, Gislason G, Nielsen OH, Hansen PR. Increased risk of venous thromboembolism and arterial cardiovascular events in patients with inflammatory bowel disease]. Ugeskr Laeger 2012;174:3003-3006.
43. Keller JJ, Wang J, Huang YL, Chou C, Wang L, Hsu J, Bai C, Chiou H. Increased risk of stroke among patients with ulcerative colitis: A population-based matched cohort study. Int J Colorectal Dis 2014;29:805-812.
44. Merrill A, Millham F. Increased risk of postoperative deep vein thrombosis and pulmonary embolism in patients with inflammatory bowel disease: A study of national surgical quality improvement program patients. Arch Surg 2012;147:120-124.
45. Deutschmann A, Schlagenhauf A, Leschnik B, Hoffmann KM, Hauer A, Muntean W. Increased procoagulant function of microparticles in pediatric inflammatory bowel disease: Role in increased thrombin generation. J Pediatr Gastroenterol Nutr 2013;56:401-407.
46. Koutroubakis IE, Malliaraki N, Vardas E, Ganotakis E, Margioris A, Manousos O, Kouroumalis E. Increased levels of lipoprotein (a) in Crohn's disease: A relation to thrombosis? Eur J Gastroenterol Hepatol 2001;13:1415-1419.
47. Lycette JL, Luoh SW, Beer TM, Deloughery TG. Acute bilateral pulmonary emboli occurring while on adjuvant aromatase inhibitor therapy with anastrozole: Case report and review of the literature. Breast Cancer Res Treat 2006;99:249-255.
48. de Ronde W, de Jong FH. Aromatase inhibitors in men: Effects and therapeutic options. Reprod Biol Endocrinol 2011;9:93-100.